ArticleClinical and translational medicine2022

CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.

An-Li Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.